The Genomics of Electroconvulsive Therapy (ECT)
This research study investigates the genetic factors that contribute to mood disorders, specifically major depressive disorder and bipolar disorder. This study also explores how genetic factors contribute to a patient’s response to Electroconvulsive Therapy (ECT).
PI: William McDonald, MD
Cognitive Behavioral Therapy Following Esketamine for Major Depression and Suicidal Ideation for Relapse Prevention (ENDURE)
This is a rater-blinded, randomized controlled trial. All patients will receive esketamine for treatment of Major Depression with Suicidal Ideation (MDSI). Subjects will be randomized (1:1) to receive CBT (computer-assisted) or TAU alone following esketamine.
For more information about depression: